We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Mandatory Surveillance of Klebsiella species (Klebsiella spp.) bacteraemia: July 2023 to July 2024
Mandatory Surveillance of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia: July 2023 to July 2024
Mandatory Surveillance of meticillin-susceptible Staphylococcus aureus (MSSA) bacteraemia: July 2023 to July 2024
Mandatory Surveillance of Pseudomonas aeruginosa (P. aeruginosa) bacteraemia: July 2023 to July 2024
Mandatory Surveillance of Clostridioides difficile infection: July 2023 to July 2024
Summary of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in England during the 2024 to 2025 season.
How the actual number of deaths in England compare with expected numbers for each week.
Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infection by financial year.
National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
This report shows all TB cases diagnosed in the UK including those detected at post-mortem.
Mandatory surveillance of healthcare associated infections (HCAI); MRSA, MSSA and Gram-negative bacteraemia (Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), Klebsiella species (Klebsiella. spp.), and Clos…
Percentage of children immunised under the Cover of Vaccination Evaluated Rapidly (COVER) programme for quarter 1, from 1 April 2024 to 30 June 2024.
Annual summary of HIV testing, HIV diagnoses, late diagnoses, access to HIV care, HIV pre-exposure prophylaxis (PrEP) and HIV post-exposure prophylaxis (PEP).
Mandatory Surveillance of meticillin-susceptible Staphylococcus aureus (MSSA) bacteraemia: August 2023 to August 2024
Mandatory Surveillance of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia: August 2023 to August 2024
Mandatory Surveillance of Clostridioides difficile infection: August 2023 to August 2024
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).